Track Shine-On BioMedical ,Ltd.'s total liabilities ($59M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 6926.TWO shows a total liabilities of $59M. That compares with $9.1M in the prior-year period — up 544.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 6926.TWO's total liabilities is now $59M (was $9.1M) — a 544.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shine-On BioMedical ,Ltd. is outperforming or lagging.
Tracking 6926.TWO's total liabilities over time shows whether Shine-On BioMedical ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $59M That compares with $9.1M in the prior-year period — up 544.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Shine-On BioMedical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $59M) with ownership activity and broader fundamentals.
Shine-On BioMedical ,Ltd.'s total liabilities is $59M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.